US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Valion Bio Inc

2.73

+0.24009.64%

Post-market: 2.65-0.0800-2.93%18:11 EDT

Volume:2.10M

Turnover:6.05M

Market Cap:2.42M

PE:-0.01

High:3.29

Open:2.45

Low:2.25

Close:2.49

52wk High:78.75

52wk Low:2.05

Shares:887.59K

Float Shares:884.65K

Volume Ratio:9.89

T/O Rate:237.49%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-210.1984

EPS(LYR):-192.0762

ROE:-459.52%

ROA:-57.13%

PB:0.57

PE(LYR):-0.01

Loading ...

Overview Company News Filings

Valion Bio appoints Dean Zikria as interim CEO, Thomas Jensen as chair

Valion Bio - Appoints Dean Zikria as Interim CEO Effective September 22, 2026 - SEC Filing

THOMSON REUTERS

Valion Bio Names Dean Zikria Interim CEO

Valion Bio regains compliance with Nasdaq minimum bid price listing rule

Valion Bio Regains NASDAQ Compliance with $1 Minimum Bid Price Rule

Valion Bio Files Initial Beneficial Ownership Statement for Director Thomas Jensen

Valion Bio Inc: Lisa Wolf Appointed as President & Chief Operating Officer; to Continue to Serve as CFO

THOMSON REUTERS

Valion Bio Names CFO Lisa Wolf President, COO After CEO Handley Exits

Valion Bio Inc trading halted, news pending

Valion Bio - 1-for-25 Reverse Stock Split, Become Effective on August 31 - SEC Filing

THOMSON REUTERS

Valion Bio Announces 1-for-25 Reverse Stock Split Effective Aug. 31

Valion Bio Amends 8-K to Report Final Vote Tally on Reverse Stock Split Approval

Valion Bio Agrees to Sell 1,500 Series B Preferred Shares to 3i for $1.5 Million in Private Placement

Valion Bio - Michael K. Handley Terminated as Chief Executive Officer, Effective August 16 - SEC Filing

THOMSON REUTERS

Valion Bio Q2 Net Loss Widens to $7.1 Million; Operating Loss Deepens to $6.4 Million

Ukraine Health Ministry Starts Technical Assessment of Valion Bio’s Entolimod Dossier

Top Premarket Decliners

MT Newswires Live

Valion Bio Says U.S.-Funded Entolimod Safety Study for Radiation-Induced GI Injury Starts This Week

NASDAQ Trade Halt Volatility Trading Pause at 09:35 Am

Valion Bio Issues 1,287 Series a Preferred Shares in Unregistered Sale Tied to $750,000 Milestone Payment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www-web.itiger.com/stock/VBIO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VBIO\",,,,,undefined,":{"symbol":"VBIO","market":"US","secType":"STK","nameCN":"Valion Bio Inc","latestPrice":2.73,"timestamp":1790193600000,"preClose":2.49,"halted":0,"volume":2100937,"hourTrading":{"tag":"盘后","latestPrice":2.65,"preClose":2.73,"latestTime":"18:11 EDT","volume":20259,"amount":56394.1821213,"timestamp":1790201510799,"change":-0.08,"changeRate":-0.029304,"amplitude":0.091575},"delay":0,"changeRate":0.09638554216867459,"floatShares":884654,"shares":887589,"eps":-210.1984,"marketStatus":"Post-Mkt","change":0.24,"latestTime":"09-23 18:12:15 EDT","open":2.45,"high":3.29,"low":2.2542,"amount":6049502.076378499,"amplitude":0.415984,"askPrice":2.89,"askSize":642,"bidPrice":2.62,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-210.1984,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790208000000},"marketStatusCode":4,"adr":0,"listingDate":1636606800000,"exchange":"NASDAQ","adjPreClose":2.49,"preHourTrading":{"tag":"盘前","latestPrice":2.43,"preClose":2.49,"latestTime":"09:28 EDT","volume":10401,"amount":26740.3344588,"timestamp":1790170106000,"change":-0.06,"changeRate":-0.024096,"amplitude":0.144578},"postHourTrading":{"tag":"盘后","latestPrice":2.65,"preClose":2.73,"latestTime":"18:11 EDT","volume":20259,"amount":56394.1821213,"timestamp":1790201510799,"change":-0.08,"changeRate":-0.029304,"amplitude":0.091575},"volumeRatio":9.892908},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VBIO\",,,,,undefined,":{"symbol":"VBIO","floatShares":884654,"roa":"-57.13%","roe":"-459.52%","lyrEps":-192.076175,"volumeRatio":9.892908,"shares":887589,"dividePrice":0,"high":3.29,"amplitude":0.415984,"preClose":2.49,"low":2.2542,"week52Low":2.05,"pbRate":"0.57","psRate":"-28.18","week52High":78.75,"institutionHeld":0,"latestPrice":2.73,"committee":-0.99689,"eps":-210.1984,"divideRate":0,"volume":2100937,"delay":0,"ttmEps":-210.1984,"open":2.45,"prevYearClose":36.25,"prevWeekClose":2.12,"prevMonthClose":3.57,"prevQuarterClose":12.9975,"fiveDayClose":2.08,"twentyDayClose":3.975,"sixtyDayClose":13.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VBIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-31","symbol":"VBIO","defaultRemindTime":1788183000000,"type":"split","dateTimestamp":1788148800000,"forFactor":25,"toFactor":1,"ratio":25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VBIO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VBIO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VBIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VBIO","date":"2026-09-22","current":-0.011846,"percent":0.673469,"low":-0.392475,"twenty":-0.191483,"median":-0.127297,"eighty":-0.074021,"high":-0.027033,"avg":-0.147656,"sd":0.083951,"marketCap":2112461},"quantilePoints":[{"date":"2026-04-30","current":-0.311197,"twenty":-0.324163,"median":-0.319301,"eighty":-0.314439,"marketCap":2762808},{"date":"2026-05-08","current":-0.33713,"twenty":-0.336482,"median":-0.327405,"eighty":-0.314439,"marketCap":2993043},{"date":"2026-05-15","current":-0.329149,"twenty":-0.341701,"median":-0.33551,"eighty":-0.327405,"marketCap":2922183},{"date":"2026-05-22","current":-0.203146,"twenty":-0.339301,"median":-0.327405,"eighty":-0.203206,"marketCap":2758322},{"date":"2026-05-29","current":-0.18116,"twenty":-0.338751,"median":-0.311197,"eighty":-0.201597,"marketCap":2459794},{"date":"2026-06-05","current":-0.173392,"twenty":-0.33713,"median":-0.203331,"eighty":-0.18116,"marketCap":2354321},{"date":"2026-06-12","current":-0.138668,"twenty":-0.333889,"median":-0.20236,"eighty":-0.175704,"marketCap":1882829},{"date":"2026-06-18","current":-0.131547,"twenty":-0.330097,"median":-0.198754,"eighty":-0.158647,"marketCap":1786145},{"date":"2026-06-26","current":-0.136114,"twenty":-0.327754,"median":-0.18598,"eighty":-0.135201,"marketCap":1848155},{"date":"2026-07-02","current":-0.122229,"twenty":-0.327405,"median":-0.179125,"eighty":-0.130362,"marketCap":1659627},{"date":"2026-07-10","current":-0.117868,"twenty":-0.31768,"median":-0.175704,"eighty":-0.126637,"marketCap":1600412},{"date":"2026-07-17","current":-0.115133,"twenty":-0.303417,"median":-0.165705,"eighty":-0.121795,"marketCap":1563282},{"date":"2026-07-24","current":-0.06742,"twenty":-0.241361,"median":-0.149117,"eighty":-0.119839,"marketCap":915435},{"date":"2026-07-31","current":-0.065535,"twenty":-0.203355,"median":-0.136114,"eighty":-0.117713,"marketCap":889829},{"date":"2026-08-07","current":-0.064804,"twenty":-0.203188,"median":-0.130843,"eighty":-0.108033,"marketCap":879906},{"date":"2026-08-14","current":-0.040264,"twenty":-0.202832,"median":-0.129351,"eighty":-0.073786,"marketCap":546700},{"date":"2026-08-21","current":-0.027033,"twenty":-0.202055,"median":-0.126472,"eighty":-0.068316,"marketCap":506868},{"date":"2026-08-28","current":-0.145091,"twenty":-0.20046,"median":-0.129351,"eighty":-0.070603,"marketCap":2720462},{"date":"2026-09-04","current":-0.132547,"twenty":-0.198079,"median":-0.130843,"eighty":-0.073078,"marketCap":2485249},{"date":"2026-09-11","current":-0.104144,"twenty":-0.196943,"median":-0.130244,"eighty":-0.073125,"marketCap":1952695},{"date":"2026-09-18","current":-0.105564,"twenty":-0.194796,"median":-0.129235,"eighty":-0.07355,"marketCap":1979323},{"date":"2026-09-22","current":-0.112665,"twenty":-0.191483,"median":-0.127297,"eighty":-0.074021,"marketCap":2112461}],"updateTime":1790166445267},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VBIO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669485224","title":"Valion Bio appoints Dean Zikria as interim CEO, Thomas Jensen as chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2669485224","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669485224?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:26","pubTimestamp":1790166377,"startTime":"0","endTime":"0","summary":"Valion Bio (VBIO) announced decisive changes to its executive leadership team and Board of Directors. These leadership transitions are intended to ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/valion-bio-appoints-dean-zikria-as-interim-ceo-thomas-jensen-as-chair-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/valion-bio-appoints-dean-zikria-as-interim-ceo-thomas-jensen-as-chair-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","VBIO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669483405","title":"Valion Bio - Appoints Dean Zikria as Interim CEO Effective September 22, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2669483405","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669483405?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:05","pubTimestamp":1790165112,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45F0MS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VBIO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669483180","title":"Valion Bio Names Dean Zikria Interim CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2669483180","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669483180?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:00","pubTimestamp":1790164859,"startTime":"0","endTime":"0","summary":"Valion Bio names Dean Zikria interim CEOValion Bio named board member Dean Zikria interim CEO to steer strategy, including Entolimod development and partnership efforts.Zikria previously held strategy","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDLYPfmS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4082","VBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669424931","title":"Valion Bio regains compliance with Nasdaq minimum bid price listing rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2669424931","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669424931?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:55","pubTimestamp":1790081710,"startTime":"0","endTime":"0","summary":"Valion Bio (VBIO) has received formal written notification from The Nasdaq Stock Market confirming that the Company has regained compliance with th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/valion-bio-regains-compliance-with-nasdaq-minimum-bid-price-listing-rule-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/valion-bio-regains-compliance-with-nasdaq-minimum-bid-price-listing-rule-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NQmain","LCLG","VBIO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669013141","title":"Valion Bio Regains NASDAQ Compliance with $1 Minimum Bid Price Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2669013141","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669013141?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:11","pubTimestamp":1790079084,"startTime":"0","endTime":"0","summary":"Valion Bio regains Nasdaq compliance with $1 minimum bid price ruleValion Bio regained compliance with Nasdaq’s $1 minimum bid price rule under Listing Rule 5550(a)(2).Nasdaq notified the company that","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL6r0dnL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VBIO","BK4139","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668992606","title":"Valion Bio Files Initial Beneficial Ownership Statement for Director Thomas Jensen","url":"https://stock-news.laohu8.com/highlight/detail?id=2668992606","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668992606?lang=en_us&edition=fundamental","pubTime":"2026-09-18 04:31","pubTimestamp":1789677107,"startTime":"0","endTime":"0","summary":"Valion Bio files initial beneficial ownership statement for director Thomas JensenValion Bio director Thomas Jensen filed an initial SEC Form 3 on Aug. 27, 2026.Disclaimer:This news brief was created ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDLNP1K2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4139","VBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664885672","title":"Valion Bio Inc: Lisa Wolf Appointed as President & Chief Operating Officer; to Continue to Serve as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2664885672","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664885672?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:08","pubTimestamp":1788264539,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T0HN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BK4139","VBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664300038","title":"Valion Bio Names CFO Lisa Wolf President, COO After CEO Handley Exits","url":"https://stock-news.laohu8.com/highlight/detail?id=2664300038","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664300038?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:09","pubTimestamp":1788257356,"startTime":"0","endTime":"0","summary":"Valion Bio names CFO Lisa Wolf president, COO after CEO Handley exitsValion Bio appointed CFO Lisa Wolf as president and COO, taking executive leadership following former CEO Michael K. Handley’s depa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDLbpTSS5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VBIO","BK4139","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663871019","title":"Valion Bio Inc trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2663871019","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663871019?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:50","pubTimestamp":1787961014,"startTime":"0","endTime":"0","summary":"19:50 EDT Valion Bio (VBIO) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/valion-bio-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/valion-bio-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","VBIO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662707915","title":"Valion Bio - 1-for-25 Reverse Stock Split, Become Effective on August 31 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2662707915","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662707915?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:33","pubTimestamp":1787833989,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O0YT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VBIO","BK4082","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662707666","title":"Valion Bio Announces 1-for-25 Reverse Stock Split Effective Aug. 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2662707666","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662707666?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:30","pubTimestamp":1787833845,"startTime":"0","endTime":"0","summary":"Valion Bio announces 1-for-25 reverse stock split effective Aug. 31Valion Bio set a 1-for-25 reverse stock split, effective Aug. 31 at 12:01 a.m. ET.Shares expected to trade split-adjusted at the open","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL9z6cwd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VBIO","BK4139","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661232321","title":"Valion Bio Amends 8-K to Report Final Vote Tally on Reverse Stock Split Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2661232321","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661232321?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:16","pubTimestamp":1787256978,"startTime":"0","endTime":"0","summary":"Valion Bio amends 8-K to report final vote tally on reverse stock split approvalValion Bio filed an amended 8-K to replace preliminary vote tallies with final results from its Aug. 14, 2026 special me","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL6tdpH8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VBIO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660481304","title":"Valion Bio Agrees to Sell 1,500 Series B Preferred Shares to 3i for $1.5 Million in Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2660481304","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660481304?lang=en_us&edition=fundamental","pubTime":"2026-08-17 18:26","pubTimestamp":1786962407,"startTime":"0","endTime":"0","summary":"Valion Bio agrees to sell 1,500 Series B preferred shares to 3i for $1.5 million in private placementValion Bio entered a $1.5 million private placement with 3i, LP, issuing 1,500 Series B Non-Voting ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL2xxr71:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","VBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660489791","title":"Valion Bio - Michael K. Handley Terminated as Chief Executive Officer, Effective August 16 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2660489791","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660489791?lang=en_us&edition=fundamental","pubTime":"2026-08-17 18:12","pubTimestamp":1786961545,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nFWN44E0GT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VBIO","BK4082","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659541124","title":"Valion Bio Q2 Net Loss Widens to $7.1 Million; Operating Loss Deepens to $6.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659541124","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659541124?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:34","pubTimestamp":1786743242,"startTime":"0","endTime":"0","summary":"Valion Bio Q2 net loss widens to $7.1 million; operating loss deepens to $6.4 millionValion Bio posted a GAAP net loss of $7.1 million for Q2 2026, widening from $1.93 million a year earlier.GAAP oper","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL5gktBH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VBIO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659688351","title":"Ukraine Health Ministry Starts Technical Assessment of Valion Bio’s Entolimod Dossier","url":"https://stock-news.laohu8.com/highlight/detail?id=2659688351","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659688351?lang=en_us&edition=fundamental","pubTime":"2026-08-13 22:00","pubTimestamp":1786629618,"startTime":"0","endTime":"0","summary":"Ukraine health ministry starts technical assessment of Valion Bio’s Entolimod dossierUkraine’s Ministry of Health accepted Valion Bio’s Entolimod dossier for formal review on July 22, 2026.Technical a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL1S7tbv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4082","VBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659159403","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2659159403","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659159403?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:30","pubTimestamp":1786620654,"startTime":"0","endTime":"0","summary":"Leslie's (LESL) shares were down more than 42% premarket Thursday following the company's fiscal Q3 financial results.Valion Bio (VBIO) stock was 30% lower, continuing from a 27% fall in the prior ses","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","OTLK","VBIO","BK4135","NCPL","BK4082","FGL","BK4200","BK4129","LESL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658890662","title":"Valion Bio Says U.S.-Funded Entolimod Safety Study for Radiation-Induced GI Injury Starts This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2658890662","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658890662?lang=en_us&edition=fundamental","pubTime":"2026-08-12 23:23","pubTimestamp":1786548204,"startTime":"0","endTime":"0","summary":"Valion Bio says U.S.-funded Entolimod safety study for radiation-induced GI injury starts this weekValion Bio disclosed a U.S. government-funded AFRRI/NIAID program testing Entolimod for lethal radiat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL77sszd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4139","VBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658290895","title":"NASDAQ Trade Halt Volatility Trading Pause at 09:35 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2658290895","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658290895?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:35","pubTimestamp":1786541720,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTVOLATILITY TRADING PAUSE AT 09:35 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nAQN2MEA1A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VBIO","BK4139","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657366395","title":"Valion Bio Issues 1,287 Series a Preferred Shares in Unregistered Sale Tied to $750,000 Milestone Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2657366395","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657366395?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:51","pubTimestamp":1786049464,"startTime":"0","endTime":"0","summary":"Valion Bio issues 1,287 Series A preferred shares in unregistered sale tied to $750,000 milestone paymentValion Bio issued 1,287 shares of Series A Preferred Stock in an unregistered sale to Statera Biopharma and Avenue Venture Opportunities Fund.Issuance dated July 31, 2026. Securities served as consideration for a $750,000 milestone payment tied to inventory validation for distribution and sales.Shares were sold in a private placement exemption under Section 4 and/or Regulation D. Securities are restricted under Rule 144.Company committed to file a resale registration statement within 60 days for common stock underlying the Series A Preferred Stock.Conversion is capped. Holders cannot exceed a beneficial ownership limit set between 4.9% and 19.9%.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should n","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL4x5jwb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VBIO","BK4082","STAB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":50,"code":"91000000","status":"200"}]}}